- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 9.04M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 9.42M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 10.08M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $3.93M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $215K |
| Capex | Q1 2026 · Mar 31, 2026 | $422K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $318K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$5.43M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$700K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $47.82M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $57.61M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $81.64M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $86.99M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $91.16M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $93.55M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.55M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $12.36M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $20.97M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $24.95M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $74.31M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $83.02M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $102.61M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $111.94M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.21 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.23 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.21 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.23 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.87M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $4.64M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $63K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $0 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.98M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.29M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.38M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$2.04M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $2.81M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $3.07M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $16.6M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $14.77M |
| Revenue | Q1 2026 · Mar 31, 2026 | $19.42M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $17.84M |